Institute for Clinical and Economic Review

Recent papers from Institute for Clinical and Economic Review

1. Dispatches from the front lines of science Lost in Curiosity Roberta Kwok Sourcebooks, 2026. 368 pp.Science · 2026
2. Timing of health technology assessment in the United States: An evaluation of ICER reviews over 8 yearsJournal of Managed Care & Specialty Pharmacy · 2026
3. Artificial Flooding Leads to Thicker and Brighter Arctic Sea IceEarth s Future · 2026
4. Editorial: The Strain of Global Shifts on Retail and Marketing2026
5. CannabisThe Chemical Educator · 2023
6. ICER’s Launch Price and Access Report: 5 key takeaways and 5 questions we should all be askingHealth Affairs Scholar · 2026
7. Ancestrally diverse autologous patient-derived organoid – immune cell co-culture platform for addressing immunotherapeutic outcome disparities in high-grade endometrial cancerCancer Research Communications · 2026
8. Playing the game of science I Told You So! Matt Kaplan St. Martin’s Press, 2026. 288 pp.Science · 2026
9. Assessing the Population-Health Loss From Funding High-Cost Medicines: Case Studies From Colombia and the Dominican RepublicValue in Health · 2026
10. Surrogate endpoints in cost-effectiveness analysis for use in health technology assessment – a qualitative analysisInternational Journal of Technology Assessment in Health Care · 2026
11. Periarticular Glenoid Osteotomy for Posterior Shoulder Instability Using Femoral Head AllograftTechniques in Orthopaedics · 2025
12. Non-Significant Correlation of Vitamin D Deficiency and Five-Year Revisions Following Adult Spinal Deformity Surgery After Controlling for Osteoporosis: A National Database AnalysisJAAOS Global Research and Reviews · 2025
13. How to make one line in the FDA Commissioner's new drug review program into a force for affordable access for patientsHealth Affairs Scholar · 2025
14. The role of diagnostic ability in markets for expert servicesEuropean Economic Review · 2025
15. Health Technology Assessment, Again: A Transparent, Evidence-Based Approach For CMS Drug Price NegotiationsHealth Affairs · 2025
16. Affordable access to GLP-1 obesity medications: strategies to guide market action and policy solutions in the USJournal of Comparative Effectiveness Research · 2025
17. GRADE Certainty Ratings: Thresholds Rather Than Categories of Contextualization (GRADE Guidance 41)Annals of Internal Medicine · 2025
18. Secondary stressors and their psychosocial impacts on healthcare staff: lessons from a qualitative systematic review from the COVID-19 pandemic in the UKBJPsych Open · 2025
19. Core GRADE 1: overview of the Core GRADE approachBMJ · 2025
20. Risk Factors of Diaphyseal Femoral Nonunions: A Systematic Review and Meta-analysisJournal of the American Academy of Orthopaedic Surgeons · 2025